- Home
- ECOR vs VATE Comparison
ECOR vs VATE Comparison
Compare ECOR & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- VATE
- Stock Information
- Founded
- ECOR 2005
- VATE 1994
- Country
- ECOR United States
- VATE United States
- Employees
- ECOR N/A
- VATE N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- VATE Metal Fabrications
- Sector
- ECOR Health Care
- VATE Industrials
- Exchange
- ECOR Nasdaq
- VATE Nasdaq
- Market Cap
- ECOR 40.1M
- VATE N/A
- IPO Year
- ECOR 2018
- VATE 1996
- Fundamental
- Price
- ECOR $5.19
- VATE $6.48
- Analyst Decision
- ECOR Strong Buy
- VATE
- Analyst Count
- ECOR 2
- VATE 0
- Target Price
- ECOR $25.50
- VATE N/A
- AVG Volume (30 Days)
- ECOR 122.7K
- VATE 18.0K
- Earning Date
- ECOR 05-07-2025
- VATE 05-06-2025
- Dividend Yield
- ECOR N/A
- VATE N/A
- EPS Growth
- ECOR N/A
- VATE N/A
- EPS
- ECOR N/A
- VATE N/A
- Revenue
- ECOR $25,182,000.00
- VATE $1,066,100,000.00
- Revenue This Year
- ECOR $32.20
- VATE N/A
- Revenue Next Year
- ECOR $46.27
- VATE N/A
- P/E Ratio
- ECOR N/A
- VATE N/A
- Revenue Growth
- ECOR 57.09
- VATE N/A
- 52 Week Low
- ECOR $5.02
- VATE $3.25
- 52 Week High
- ECOR $19.49
- VATE $13.79
- Technical
- Relative Strength Index (RSI)
- ECOR 31.29
- VATE 48.03
- Support Level
- ECOR $6.01
- VATE $5.74
- Resistance Level
- ECOR $7.14
- VATE $6.95
- Average True Range (ATR)
- ECOR 0.80
- VATE 0.47
- MACD
- ECOR 0.07
- VATE 0.10
- Stochastic Oscillator
- ECOR 3.99
- VATE 67.59
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.